Cargando…
An Overview on GPCRs and Drug Discovery: Structure-Based Drug Design and Structural Biology on GPCRs
G protein-coupled receptors (GPCRs) represent 50–60% of the current drug targets. There is no doubt that this family of membrane proteins plays a crucial role in drug discovery today. Classically, a number of drugs based on GPCRs have been developed for such different indications as cardiovascular,...
Autor principal: | Lundstrom, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122359/ https://www.ncbi.nlm.nih.gov/pubmed/19513641 http://dx.doi.org/10.1007/978-1-60327-317-6_4 |
Ejemplares similares
-
GPCRs in Intracellular Compartments: New Targets for Drug Discovery
por: Fasciani, Irene, et al.
Publicado: (2022) -
Editorial: Monitoring endogenous GPCRs: lessons for drug design
por: Massotte, Dominique
Publicado: (2015) -
Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery
por: Krishna Deepak, R. N. V., et al.
Publicado: (2021) -
Ion Channels as Drug Targets: The Next GPCRs
por: Kaczorowski, Gregory J., et al.
Publicado: (2008) -
Editorial: Orphan GPCRs As Emerging Drug Targets
por: Fang, Ye, et al.
Publicado: (2015)